Literature DB >> 34076506

Large Clostridial Toxins: Mechanisms and Roles in Disease.

Kathleen E Orrell1,2, Roman A Melnyk1,2.   

Abstract

Large clostridial toxins (LCTs) are a family of bacterial exotoxins that infiltrate and destroy target cells. Members of the LCT family include Clostridioides difficile toxins TcdA and TcdB, Paeniclostridium sordellii toxins TcsL and TcsH, Clostridium novyi toxin TcnA, and Clostridium perfringens toxin TpeL. Since the 19th century, LCT-secreting bacteria have been isolated from the blood, organs, and wounds of diseased individuals, and LCTs have been implicated as the primary virulence factors in a variety of infections, including C. difficile infection and some cases of wound-associated gas gangrene. Clostridia express and secrete LCTs in response to various physiological signals. LCTs invade host cells by binding specific cell surface receptors, ultimately leading to internalization into acidified vesicles. Acidic pH promotes conformational changes within LCTs, which culminates in translocation of the N-terminal glycosyltransferase and cysteine protease domain across the endosomal membrane and into the cytosol, leading first to cytopathic effects and later to cytotoxic effects. The focus of this review is on the role of LCTs in infection and disease, the mechanism of LCT intoxication, with emphasis on recent structural work and toxin subtyping analysis, and the genomic discovery and characterization of LCT homologues. We provide a comprehensive review of these topics and offer our perspective on emerging questions and future research directions for this enigmatic family of toxins.

Entities:  

Keywords:  Clostridium difficile; large clostridial toxin; toxin; toxin-mediated diseases; toxin-receptor interaction

Mesh:

Substances:

Year:  2021        PMID: 34076506      PMCID: PMC8483668          DOI: 10.1128/MMBR.00064-21

Source DB:  PubMed          Journal:  Microbiol Mol Biol Rev        ISSN: 1092-2172            Impact factor:   13.044


  279 in total

1.  Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.

Authors:  Carrie A Cowardin; Brianna M Jackman; Zannatun Noor; Stacey L Burgess; Andrew L Feig; William A Petri
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

2.  Toxins A and B from Clostridium difficile differ with respect to enzymatic potencies, cellular substrate specificities, and surface binding to cultured cells.

Authors:  E Chaves-Olarte; M Weidmann; C Eichel-Streiber; M Thelestam
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

3.  Interspecies conversion of Clostridium botulinum type C to Clostridium novyi type A by bacteriophage.

Authors:  M W Eklund; F T Poysky; J A Meyers; G A Pelroy
Journal:  Science       Date:  1974-11-01       Impact factor: 47.728

4.  Sequencing and analysis of the gene encoding the alpha-toxin of Clostridium novyi proves its homology to toxins A and B of Clostridium difficile.

Authors:  F Hofmann; A Herrmann; E Habermann; C von Eichel-Streiber
Journal:  Mol Gen Genet       Date:  1995-06-25

5.  Autopsy findings in an outbreak of severe systemic illness in heroin users following injection site inflammation: an effect of Clostridium novyi exotoxin?

Authors:  Stephen P Finn; Eamon Leen; Liam English; D Sean O'Briain
Journal:  Arch Pathol Lab Med       Date:  2003-11       Impact factor: 5.534

6.  Paraclostridium benzoelyticum gen. nov., sp. nov., isolated from marine sediment and reclassification of Clostridium bifermentans as Paraclostridium bifermentans comb. nov. Proposal of a new genus Paeniclostridium gen. nov. to accommodate Clostridium sordellii and Clostridium ghonii.

Authors:  T S Sasi Jyothsna; L Tushar; Ch Sasikala; Ch V Ramana
Journal:  Int J Syst Evol Microbiol       Date:  2016-01-05       Impact factor: 2.747

7.  R-Ras glucosylation and transient RhoA activation determine the cytopathic effect produced by toxin B variants from toxin A-negative strains of Clostridium difficile.

Authors:  Esteban Chaves-Olarte; Enrique Freer; Andrea Parra; Caterina Guzmán-Verri; Edgardo Moreno; Monica Thelestam
Journal:  J Biol Chem       Date:  2002-12-19       Impact factor: 5.157

8.  Clostridium difficile toxin expression is inhibited by the novel regulator TcdC.

Authors:  Susana Matamouros; Patrick England; Bruno Dupuy
Journal:  Mol Microbiol       Date:  2007-06       Impact factor: 3.501

9.  Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.

Authors:  Glen P Carter; Anjana Chakravorty; Tu Anh Pham Nguyen; Steven Mileto; Fernanda Schreiber; Lucy Li; Pauline Howarth; Simon Clare; Bliss Cunningham; Susan P Sambol; Adam Cheknis; Iris Figueroa; Stuart Johnson; Dale Gerding; Julian I Rood; Gordon Dougan; Trevor D Lawley; Dena Lyras
Journal:  MBio       Date:  2015-06-02       Impact factor: 7.867

10.  The Conserved Cys-2232 in Clostridioides difficile Toxin B Modulates Receptor Binding.

Authors:  Soo-Young Chung; Dennis Schöttelndreier; Helma Tatge; Viola Fühner; Michael Hust; Lara-Antonia Beer; Ralf Gerhard
Journal:  Front Microbiol       Date:  2018-10-26       Impact factor: 5.640

View more
  13 in total

Review 1.  From signal transduction to protein toxins-a narrative review about milestones on the research route of C. difficile toxins.

Authors:  Klaus Aktories
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-10-07       Impact factor: 3.195

Review 2.  Clostridioides difficile toxins: mechanisms of action and antitoxin therapeutics.

Authors:  Shannon L Kordus; Audrey K Thomas; D Borden Lacy
Journal:  Nat Rev Microbiol       Date:  2021-11-26       Impact factor: 78.297

3.  Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.

Authors:  Baohua Chen; Zheng Liu; Kay Perry; Rongsheng Jin
Journal:  Sci Rep       Date:  2022-05-30       Impact factor: 4.996

Review 4.  Host Immune Responses to Clostridioides difficile: Toxins and Beyond.

Authors:  Britt Nibbering; Dale N Gerding; Ed J Kuijper; Romy D Zwittink; Wiep Klaas Smits
Journal:  Front Microbiol       Date:  2021-12-21       Impact factor: 5.640

5.  Structure and conformational dynamics of Clostridioides difficile toxin A.

Authors:  Baohua Chen; Sujit Basak; Peng Chen; Changcheng Zhang; Kay Perry; Songhai Tian; Clinton Yu; Min Dong; Lan Huang; Mark E Bowen; Rongsheng Jin
Journal:  Life Sci Alliance       Date:  2022-03-15

6.  Paeniclostridium sordellii hemorrhagic toxin targets TMPRSS2 to induce colonic epithelial lesions.

Authors:  Xingxing Li; Liuqing He; Jianhua Luo; Yangling Zheng; Yao Zhou; Danyang Li; Yuanyuan Zhang; Zhenrui Pan; Yanyan Li; Liang Tao
Journal:  Nat Commun       Date:  2022-07-26       Impact factor: 17.694

7.  Clostridiumnovyi's Alpha-Toxin Changes Proteome and Phosphoproteome of HEp-2 Cells.

Authors:  Theresa Schweitzer; Harald Genth; Andreas Pich
Journal:  Int J Mol Sci       Date:  2022-09-01       Impact factor: 6.208

8.  LDLR, LRP1, and Megalin redundantly participate in the uptake of Clostridium novyi alpha-toxin.

Authors:  Yao Zhou; Danyang Li; Diyin Li; Aizhong Chen; Liuqing He; Jianhua Luo; Liang Tao
Journal:  Commun Biol       Date:  2022-09-05

9.  Prevalence and Antimicrobial Resistance of Paeniclostridium sordellii in Hospital Settings.

Authors:  Hanane Zerrouki; Sid-Ahmed Rebiahi; Yamina Elhabiri; Ahlam Fatmi; Sophie Alexandra Baron; Isabelle Pagnier; Seydina M Diene; Jean-Marc Rolain
Journal:  Antibiotics (Basel)       Date:  2021-12-29

10.  The Essential Role of Rac1 Glucosylation in Clostridioides difficile Toxin B-Induced Arrest of G1-S Transition.

Authors:  Lara Petersen; Svenja Stroh; Dennis Schöttelndreier; Guntram A Grassl; Klemens Rottner; Cord Brakebusch; Jörg Fahrer; Harald Genth
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.